Clinical Trials
7 trialsNCT03242382 2024-01-23
PalboSarc
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Unknown
NCT01811394 2023-12-06
ISAC
Heidelberg University
Phase 2 Unknown
NCT06140732 2023-11-20
Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Xuanwu Hospital, Beijing
Phase 2 Unknown
NCT05707767 2023-07-19
A Prospective Study of Surgical Treatment Strategies for Chordoma
Xuanwu Hospital, Beijing
Phase NA Unknown
NCT04042597 2019-08-05
CSSG-03
Peking University People's Hospital
Phase 2 Unknown
NCT01175109 2012-12-27
Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma
University of Virginia
Phase 1 Unknown
NCT01182779 2010-08-17
HIT-1
Heidelberg University
Phase 3 Unknown